Antibodies on this scale are not _produced_ by animals. The way these things work is an antibody that binds to a specific target will be _discovered_ by immunizing animals and then screening it's blood or lymph nodes for antibodies of interest. Once an antibody is found and commercialized, it is produced in large bioreactors of cell cultures engineered to produce large amounts of a particular protein (in this case the antibody).
Source: work as a software dev at a company developing antibody drugs
Isn't that exactly what they're doing here? My understanding is Deno is asking the courts to invalidate Oracle's JavaScript trademark, making it a generic term in the public domain. They are not asking for the mark to be re-assigned to Deno.
It worth noting that the power of the neural engine doubled between the A16 and A17 chips (17 vs 35 TOPS, according to Wikipedia), while the A15 to A16 was a much more modest increase (15.8 to 17 TOPS). So it does seem like they started prioritizing AI/ML performance with the A17 design.
In my last two jobs, one in the Bay Area and one in Vancouver, my usual schedule has been arrive at 9, take a 45-60min lunch, leave at 5 and I've never had anyone tell me I'm not working enough or producing enough output.
Source: work as a software dev at a company developing antibody drugs